AVTX
Avalo Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.62 / 10
Netural
Fund flow evaluation: 7.55/10 reflecting robust fund flow characteristics. Constructive Medium trends face headwinds from adverse overall, block, Small, Large, and Extra-large developments, indicating positive money flow direction. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 2 research evaluations, supported by 1.69 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-15
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for AVTX?
- AVTX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.62/10 (Netural).
